Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability

British Journal of Clinical Pharmacology
D E NewbyD J Webb

Abstract

The current studies were designed to characterize the pharmacology, reproducibility and tolerability of the vasodilator response to intra-arterial substance P infusion in the forearm of healthy man. On different occasions, eight healthy male volunteers received brachial artery infusions of substance P at doubling doses ranging from 0.5 to 128 pmol min(-1). Blood flow was measured in both arms using venous occlusion plethysmography. Substance P induced dose-dependent vasodilatation in the human forearm which had a log-linear relationship to dose. At doses of 1-8 pmol min(-1), mean responses were highly reproducible both within and between days. There were no differences between responses to discontinuous doses and continuous doses of substance P. Substance P was generally well tolerated at doses of < or = 64 pmol min(-1) with no significant alteration in arterial blood pressure or heart rate. Skin oedema in the infused forearm and systemic vasodilatation, manifested by facial flushing and non-infused forearm vasodilatation, occurred at doses of > or = 16 pmol min(-1). Forearm vasodilatation to substance P represents a reproducible and useful model in the assessment of peripheral endothelial cell NK1 receptor function.

Citations

Feb 2, 2002·Current Atherosclerosis Reports·Stanley Chia, David E Newby
Nov 8, 2001·European Journal of Pharmacology·F J HuygenF J Zijlstra
Jan 22, 2003·Journal of the American College of Cardiology·Stanley ChiaDavid E Newby
Nov 7, 2000·Acta Anaesthesiologica Scandinavica·B OsterlundB Biber
Oct 24, 2002·British Journal of Clinical Pharmacology·Fiona E StrachanDavid J Webb
Apr 28, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·D R MeekingM H Cummings
May 31, 2003·Mediators of Inflammation·Freek J ZijlstraJan Klein
Oct 13, 2011·European Heart Journal·Christian M PedersenNicholas L Cruden
Dec 3, 2010·BMC Neurology·Floris H Vanmolkot, Jan N de Hoon
Sep 16, 2008·Biochemical Pharmacology·Ninian N LangDavid E Newby
May 3, 2008·Journal of the American College of Cardiology·Ingibjörg J GudmundsdóttirDavid E Newby
Jan 12, 2016·British Journal of Clinical Pharmacology·Christian M PedersenNinian N Lang
Jun 9, 2016·British Journal of Clinical Pharmacology·Colin G StirratDavid E Newby
Mar 24, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Marie HauerslevMichael Rahbek Schmidt
Mar 26, 2013·Journal of the American Heart Association·Sowmya VenkatasubramanianDavid E Newby
Jul 10, 2007·Journal of Peptide Science : an Official Publication of the European Peptide Society·Sudhanand PrasadRama Mukherjee
Nov 27, 2008·Journal of Cardiovascular Pharmacology·Ninian N LangDavid E Newby
Jul 24, 2008·Anesthesiology·Astrid J TerkelsenTroels S Jensen
Dec 28, 2017·Naunyn-Schmiedeberg's Archives of Pharmacology·Nadia M J RupniakKarl B Thor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.